Top Wall Street analysts changed outlook on top names. Baird raised PSN target, BTIG cut WMT target,

BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price targe

HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's

Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the pri

MDxHealth SA (NASDAQ:MDXH) stock skyrocketed on Friday after the diagnostic company reported mixed q

MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue tes

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular

Dow falls 0.26% while Nasdaq drops 0.51%. Energy shares rise 1.3%, tech stocks fall 0.6%. US retail

US stocks mixed, Nasdaq up 0.2%. Retail sales down 0.6% in July. Wetour Robotics up 150%, while Innv

MDxHealth SA (MDXH) Q2 2026 Earnings Call Transcript

MDxHealth SA (MDXH) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Est

On Thursday, MDxHealth (NASDAQ:MDXH) discussed second-quarter financial results during its earnings

Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session

MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $110.000 million-$115.000 million to $110.

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.18) per share which missed the analyst cons

Second quarter r evenue gr owth of 1 6 % to $ 2 7 . 2 million Conference call with Q&A today at 4 :

Company to Host Conference Call with Live Q&A, August 13, 2026, at 4:30pm ET / 22:30 CET IRVINE, Cal

Mdxhealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focus

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securiti

Mdxhealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focus

IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "m

The publication represents the first major peer-reviewed milestone from the Oxford collaboration and

Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncolog

Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the pri

TD Cowen analyst Dan Brennan maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price ta

US stocks up, Dow gains 250+ pts. Tech sector up 0.8%, healthcare down 0.3%. Retail sales rise 0.5%

Analyst ratings for top names changed: Doximity cut to neutral, National Vision lowered price target

BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price targe

Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. S

MDxHealth NASDAQ: MDXH reported first-quarter 2026 revenue of $27.4 million while announcing a strat

MDxHealth SA (MDXH) Q1 2026 Earnings Call Transcript

MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.0

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst cons

Mdxhealth Reports Q1-2026 Results Conference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, C

Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will releas

MDxHealth SA (NASDAQ: MDXH - Get Free Report) has earned a consensus rating of "Moderate Buy" from t

MDxHealth (NASDAQ: MDXH - Get Free Report) and Health Catalyst (NASDAQ: HCAT - Get Free Report) are

Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Te

MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript

MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $137.000 million-$140.000 million to $137.

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst cons

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on Feb

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidan

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment eff